Don’t let the high cost of brand sustained-release ocular lubricant insert disrupt your dry eye care. We help eligible patients access Lacrisert (hydroxypropyl cellulose ophthalmic insert 5 mg) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
The Lacrisert Patient Assistance Program is a manufacturer-sponsored initiative that helps eligible patients access Lacrisert (used for moderate-to-severe dry eye syndrome through sustained tear-film stabilization) at little or no cost when they meet specific income, insurance, and clinical criteria. The program is free to apply for, but the enrollment process involves detailed applications, ophthalmology coordination, supporting documentation, and ongoing renewal — which can be overwhelming when you are managing a chronic ocular surface disease.
At AffordMyPrescriptions, our Patient Advocates handle the entire Lacrisert PAP enrollment for a flat $69.95 per month. We complete the application, coordinate with your prescriber for required medical documentation, follow up with the manufacturer’s program until approval, manage your refills, and handle annual re-certification — so you never face a gap in your Lacrisert dry eye therapy.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your Lacrisert enrollment — from the initial application through ongoing refills and annual re-enrollment — so you never face a gap in your dry eye treatment.
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$480/mo | Save substantially |
| CVS Pharmacy | ~$500/mo | Save substantially |
| Walmart | ~$340/mo | Save substantially |
| Costco | ~$320/mo | Save substantially |
| Generic cyclosporine 0.05% | ~$60/mo | Generic Rx alt |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. AffordMyPrescriptions Advocacy Service bypasses pharmacy pricing entirely by using the manufacturer’s assistance program to secure your Lacrisert — independent of dosage or retail price.
1 Medications
2 Medications
3 Medications
4+ Medications
The Lacrisert Patient Assistance Program is free to apply and provides medication at no cost if approved. But the process involves detailed applications, prescriber coordination, documentation, and ongoing management — applications that are commonly delayed or denied when paperwork is incomplete. Our $69.95 per month covers full advocacy: applications, doctor coordination, documentation, refill management, and re-enrollment — so you focus on your health, not paperwork. For many patients with dry eye, OTC artificial tears, warm compresses, and lid hygiene are very inexpensive first-line, with generic cyclosporine 0.05% as an effective anti-inflammatory Rx alternative.
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Lacrisert:
Coupon cards expire and require constant renewal
Still $300–$500/month per month even with the best discount
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Lacrisert assistance.
Lacrisert is a sustained-release ophthalmic insert containing hydroxypropyl cellulose. A small rod-shaped insert is placed in the lower conjunctival sac once daily, where it gradually dissolves over 24 hours, releasing hydroxypropyl cellulose to thicken and stabilize the tear film. Useful for patients with severe dry eye whose symptoms persist despite frequent artificial tear use.
How It Works:
Dry eye syndrome (keratoconjunctivitis sicca) involves tear-film instability, inflammation, and ocular surface damage. Causes include aqueous deficiency (lacrimal gland dysfunction), evaporative loss (meibomian gland dysfunction), or a mix of both.
Hydroxypropyl cellulose is a water-soluble polymer that stabilizes and thickens the tear film when slowly released from the Lacrisert insert. Once-daily insertion offers sustained tear-film support without the need for frequent eye drop instillation throughout the day. The insert dissolves gradually and does not require removal.
Form and Use:
Lacrisert 5 mg insert. One insert placed in the lower conjunctival sac once daily using the supplied applicator. Some patients use one insert twice daily for more severe symptoms. After insertion, the insert gradually dissolves over the day. Clean hands and supplies before each insertion. May cause transient blurred vision after insertion.
Generic Availability:
No generic Lacrisert. Other dry eye therapies — Rx anti-inflammatory: cyclosporine 0.05% (Restasis — generic now available), Cequa, Vevye, Xiidra (lifitegrast), Miebo (evaporative dry eye), Tyrvaya (nasal spray), Eysuvis (short-term flare). OTC artificial tears/gels (extensive options — preservative-free for frequent use). Warm compresses, lid hygiene, oral omega-3 (mixed evidence). Punctal plugs (preserve natural tears). Autologous serum tears for severe disease. Lifitegrast and cyclosporine are anti-inflammatory; Miebo reduces evaporation; Lacrisert offers sustained mechanical lubrication.
Warnings:
Transient blurred vision (most common — usually immediately after insertion as insert dissolves), eye discomfort or irritation, matting or stickiness of eyelashes, photophobia, hyperemia, edema of eyelids, hypersensitivity. Insert may extrude or migrate. Stop use and consult ophthalmology if persistent irritation, vision changes, or signs of infection occur.
Brand Lacrisert $300–$500 per month for typical 60-insert supply. Generic cyclosporine 0.05% (Restasis alternative) about $50–$80 per month. OTC artificial tears $10–$20 per month.
Using the supplied applicator, place one insert in the lower conjunctival sac once daily (or twice daily per prescriber). Wash hands first. Some practice may be needed to comfortably insert. The insert gradually dissolves over the day — no removal needed.
Artificial tears (drops or gels) provide brief lubrication but wash out quickly. Lacrisert is a sustained-release insert that provides hydroxypropyl cellulose throughout the day from a single morning placement. Useful when frequent drop instillation is impractical or symptoms persist despite tears.
Yes — Lacrisert is often combined with anti-inflammatory Rx therapy (Restasis/cyclosporine, Xiidra, Miebo), OTC tears for breakthrough symptoms, warm compresses and lid hygiene for MGD, and punctal plugs. Discuss the combination strategy with your ophthalmologist.
Immediately after insertion, the dissolving hydroxypropyl cellulose briefly thickens the tear film, which can blur vision for a short time. This typically clears within minutes. Persistent or severe blurring should be evaluated.
Yes — designed for chronic dry eye management. Monitor for ongoing comfort, vision changes, and signs of infection or hypersensitivity. Combine with disease-modifying anti-inflammatory therapy and lid care as appropriate.
We help explore generic cyclosporine 0.05% (Restasis alternative — much cheaper, anti-inflammatory), Xiidra/Miebo copay programs (alternative anti-inflammatory or anti-evaporative Rx), OTC artificial tears and gels (very cheap first-line), punctal plug procedures, warm compress and lid hygiene routines, and Patient Advocate Foundation or dry eye foundation support.
Chronic dry eye management should not be skipped over cost. OTC tears, lid hygiene, and generic cyclosporine 0.05% are inexpensive effective first-line options for many patients. Our Lacrisert advocacy team is ready to verify your eligibility, complete the manufacturer application on your behalf, and manage your prescription through approval, delivery, and renewal — for a flat $69.95 per month. If we cannot help you access Lacrisert through a Patient Assistance Program, you are not charged. Call (833) 556-2729 or check your eligibility online today.
Start free by filling out a simple online form.
Our specialist will contact you for a quick welcome call.
Our team handles everything, so you can focus on your health.